Table 3.
Stability estimates for CPM within and between sessions for the overall sample
| Clinical cohort | ICC’s for the absolute difference (95% CI) | ICC’s for the percent change (95% CI) | SEM* | MDC* | |
|---|---|---|---|---|---|
| Within session |
CPM trial 1-CPM trial 2 (baseline) |
0.54 (0.34-0.68) |
0.42 (0.16-0.59) |
6.79 |
18.82 |
| CPM trial 1-CPM trial 2 (3 months) |
0.62 (0.43-0.74) |
0.07 (-0.51-0.36) |
5.96 |
16.52 |
|
|
Healthy cohort | |||||
| Within session |
CPM trial 1-CPM trial 2 (day 1) |
0.66 (0.55-0.75) |
0.60(0.46-0.70) |
6.37 |
17.66 |
| CPM trial 1-CPM trial 2 (day 3) |
0.72 (0.62-0.79) |
0.55 (0.39-0.67) |
6.30 |
17.46 |
|
| CPM trial 1-CPM trial 2 (day 5) |
0.70 (0.60-0.78) |
0.64 (0.51-0.73) |
6.40 |
17.74 |
|
| Between session |
CPM trial 1 (day1)-CPM trial 1 (day3)-CPM trial 1 (day5) |
0.71(0.62-0.77) |
0.61 (0.49-0.70) |
6.75 |
18.71 |
| CPM trial 2 (day1)-CPM trial 2 (day3)-CPM trial 2 (day5) | 0.68 (0.60-0.76) | 0.59 (0.46-0.69) | 5.93 | 16.44 | |
*SEM and MDC were calculated using ICC’s for the absolute difference of CPM.